| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/06/2010 | CN101041690B Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof |
| 10/06/2010 | CN100999550B Tubercle branch bacillus fusion protein and application thereof |
| 10/05/2010 | US7807886 Tomato variety Picus |
| 10/05/2010 | US7807885 Tomato line FIR 128-1018 |
| 10/05/2010 | US7807876 Antimicrobial peptides and methods of use |
| 10/05/2010 | US7807874 Stress tolerant plants and methods thereof |
| 10/05/2010 | US7807872 Inhibitor of cyclin-dependent kinase (ICK) nucleic acid and polypeptide molecules, useful as modulating agents in regulating cell cycle progression in plants |
| 10/05/2010 | US7807870 Using transgenic plants as bioreactors for synthesis of hemoglobin |
| 10/05/2010 | US7807865 Transgene assay using stable agrobacterium rhizogenes transformation |
| 10/05/2010 | US7807862 Transgenic bovine comprising human growth hormone in its serum and methods of making |
| 10/05/2010 | US7807813 Kit comprising amplification primers and an internal control sequence for use in detection of west nile viral genomes; assuring safety of blood supply |
| 10/05/2010 | US7807810 Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby |
| 10/05/2010 | US7807808 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a SecA protein with increased levels of protein secretion, and method for producing proteins |
| 10/05/2010 | US7807806 Composition comprising nucleic acid which forms cleavable nucleic acid structure on specific target sequences in a site-specific manner |
| 10/05/2010 | US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy |
| 10/05/2010 | US7807796 ULBP antibodies |
| 10/05/2010 | US7807795 Antibodies to osteoprotegerin binding proteins |
| 10/05/2010 | US7807792 Wilms tumor protein-1 (WT1) for use in treatment and prevention of celll proliferative disorders; antitumor agents |
| 10/05/2010 | US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders |
| 10/05/2010 | US7807786 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation |
| 10/05/2010 | US7807785 Androgen regulated prostate specific nucleic acids |
| 10/05/2010 | US7807784 Immunosuppression of lymphocytes by introducing a cDNA molecule encoding mutant LIGHT into the tumor, and expressing the cDNA molecule; antitumor agents, tumor antigens; drug screening |
| 10/05/2010 | US7807783 Fas associating protein with a novel death domain(FADD) for use in treatment and prevention programmed cell death associated disorders |
| 10/05/2010 | US7807782 Using targeted reactions between proline and adapter segments as tool in generation of preferential fusion proteins; directed protein evolution |
| 10/05/2010 | US7807780 Multi-component biological transport systems |
| 10/05/2010 | US7807778 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 10/05/2010 | US7807777 Marker peptide for alzheimer's disease |
| 10/05/2010 | US7807641 Methods and reagents for treating glucose metabolic disorders |
| 10/05/2010 | US7807640 stimulate the formation and cycling of pre-beta high density lipoprotein-like particles and/or promote lipid transport and detoxification and inhibit osteoporosis; class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini; atherosclerosis |
| 10/05/2010 | US7807636 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis; biodrug for reducing or preventing damage to tissue or organs caused by acute inflammatory response in a bovine; veterinary medicine |
| 10/05/2010 | US7807628 Therapeutic agent for dentin-pulp complex regeneration |
| 10/05/2010 | US7807627 treating bone disorders related to bone, cartilage, tendon or tooth formation; recombinant BMP protein having a heparin binding site; expressing a BMP protein in a bacterial E. Coli host; low immunogenicity |
| 10/05/2010 | US7807624 coating a vascular device stent with a biofunctional coating composition comprises a surface-binding domain and an endothelial-cell binding domain, both are coupled together; promoting endothelialization on the implanted device; healing of tissue; reduce occurrence of thrombosis and restenosis |
| 10/05/2010 | US7807622 Composition and use of phyto-percolate for treatment of disease |
| 10/05/2010 | US7807620 Synthetic, for the enhancement of fertility, egg production and/or spermatogenesis |
| 10/05/2010 | US7807619 Compositions and methods for modification of biomolecules |
| 10/05/2010 | US7807617 Peptide inhibitors of toxins derived from LL-37 |
| 10/05/2010 | US7807455 Generating viral replicon having an increased replication activity in a Huh7 cells using variant viral coding sequences; prevention and treatment of liver inflammation, infection and failure |
| 10/05/2010 | US7807444 Prokaryotic recombinant host cell for use as bioreactor; improved heteroloogous gene expression |
| 10/05/2010 | US7807443 Microorganisms providing novel gene products forming or decomposing polyamino acids |
| 10/05/2010 | US7807442 PUFA polyketide synthase systems and uses thereof |
| 10/05/2010 | US7807441 Nucleotide sequences which code protein that induces cytotoxic T-lymphocyte immunity against weak selfproteins; antitumor agents |
| 10/05/2010 | US7807438 Vessicular composition comprising hepatitis C virus RNA sequences for use in designing drugs for treatment and prevention of viral infection |
| 10/05/2010 | US7807436 Recombinant host for producing L-asparaginase II |
| 10/05/2010 | US7807430 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 10/05/2010 | US7807421 Process for production of biopterin compound |
| 10/05/2010 | US7807413 making modified human Interleukin-8 (IL-8) protein; inhibition of the interaction of chemokines and their high-affinity receptors on leukocytes and methods for the therapeutic treatment of inflammatory diseases; glycosaminoglycan-binding proteins (GAG) |
| 10/05/2010 | US7807412 Using platelete derived growth fator as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 10/05/2010 | US7807410 Using vector transformation to generate transgenic organism which can express heterologous protein in high and low temperatures |
| 10/05/2010 | US7807405 Drug delivery; drug targetting |
| 10/05/2010 | US7807390 G-protein coupled receptor ligands and methods |
| 10/05/2010 | US7807388 Expression vector comprising nucleotide sequences coding membrane channel protein for use in identifying modulators for pain |
| 10/05/2010 | US7807387 Biological agent that causes IL-6 receptor release |
| 10/05/2010 | US7807386 Peptides for discrimination of prions |
| 10/05/2010 | US7807385 Method of detecting PRO9917 |
| 10/05/2010 | US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule |
| 10/05/2010 | US7807380 antibodies that specifically bind to native proBNP; method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP; biomarkers |
| 10/05/2010 | US7807373 Prostate specific gene, PCGEM1, and methods of using PCEGM1 to detect, treat, and prevent prostate cancer |
| 10/05/2010 | US7807357 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering |
| 10/05/2010 | US7807355 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 10/05/2010 | US7807346 Using fusion protein comprised of terminal reporter molecules to rapidly detect virus binding and entry into cells; receptor-dependent targeted therapy; viricides |
| 10/05/2010 | US7807184 Heat resistant, chimeric verotoxin subunits for use in developing vaccine for prevention and treatment of microorganismal infection |
| 10/05/2010 | US7807181 Genetic engineered mutants lipid |
| 10/05/2010 | US7807178 Muteins of placental growth factor type I, preparation method and application thereof |
| 10/05/2010 | US7807177 Segment of glycosylation-deficient HGFalpha-chain |
| 10/05/2010 | US7807176 Polypeptide promoting vascular endothelial cell growth |
| 10/05/2010 | US7807173 Avian influenza; Hemagglutinin |
| 10/05/2010 | US7807164 Lyophilized VEGF antagonist formulations for intravitreal administration |
| 10/05/2010 | US7807163 Antibodies against GPR64 and uses thereof |
| 10/05/2010 | US7807153 Apo-2 receptor agonist antibodies |
| 10/05/2010 | US7807148 Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a |
| 10/05/2010 | US7807141 Tooth pellicle-binding peptide; binding to oral cavity surfaces, teeth and gums |
| 10/05/2010 | US7807133 Diagnosis, therapy of tumors; as compared to avidin, the diavidins have shown ability to increase amount of labelled biotin on target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H |
| 10/05/2010 | CA2444809C A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 10/05/2010 | CA2428662C Small acid-soluble spore protein and uses thereof |
| 10/05/2010 | CA2298438C Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
| 10/05/2010 | CA2233071C Use of growth hormone for recovering renal function |
| 10/05/2010 | CA2157219C Process for purifying recombinant human serum albumin |
| 10/05/2010 | CA2086325C Ligand for cd28 receptor on b cells and methods |
| 09/30/2010 | WO2010111687A2 Methods and compositions for immunization against virus |
| 09/30/2010 | WO2010111625A1 Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination |
| 09/30/2010 | WO2010111597A2 Immunodominant compositions and methods of use therefor |
| 09/30/2010 | WO2010111568A2 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding snf2 domain-containing polypeptides |
| 09/30/2010 | WO2010111516A2 Compositions and methods for inhibiting biofilms |
| 09/30/2010 | WO2010111485A1 Compositions for stimulation of mammalian innate immune resistance to pathogens |
| 09/30/2010 | WO2010111421A2 Isoform nell-1 peptide |
| 09/30/2010 | WO2010111292A1 Treatment of cancer with immunostimulatory hiv tat derivative polypeptides |
| 09/30/2010 | WO2010111273A1 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 09/30/2010 | WO2010111220A1 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof |
| 09/30/2010 | WO2010110596A2 Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same |
| 09/30/2010 | WO2010110503A1 INTERFERON-α (IFN-α) FUSED PROTEIN HAVING IFN-α AND CYTOPLASMIC TRANSDUCTION PEPTIDE (CTP) |
| 09/30/2010 | WO2010110455A1 Polyion complex comprising hydrophobized polyamino acid and use of same |
| 09/30/2010 | WO2010110288A1 Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand |
| 09/30/2010 | WO2010110067A1 Crosslinked material comprising elastin and collagen, and use thereof |
| 09/30/2010 | WO2010109874A1 Koi herpes virus-specific antibody and antigen thereof |
| 09/30/2010 | WO2010109555A1 Risk marker for carcinogenesis caused by inhalation exposure to nanoparticles and use of same |
| 09/30/2010 | WO2010109066A1 Dysfunction of the mitochondrial respiratory chain, methods for diagnosis, treatment and follow-up |
| 09/30/2010 | WO2010109053A1 Methods and compositions for the treatment of cirrhosis and liver fibrosis |
| 09/30/2010 | WO2010109042A1 Composition for the prevention or treatment of diabetes mellitus |
| 09/30/2010 | WO2010109010A1 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them |